Gsk Plc-spon Adr. (GSK)
$39.07
Gsk Plc-spon Adr. (GSK) Share Price Forecast
Currently 33 wall-street analysts regularly analyze the financials of Gsk Plc-spon Adr. on a frequent basis to provide recommendations along with target share price. 33 analysts offering 12-month price forecasts for Gsk Plc-spon Adr. (GSK) have a share price target of $45.88. This median of share price forecast represents a 17.43% upside from the latest price of $39.07 as on 12.10.24.
Gsk Plc-spon Adr. (GSK) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Gsk Plc-spon Adr. (GSK) share price will touch around $45.88 in next 12-months.
Gsk Plc-spon Adr. (GSK) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Gsk Plc-spon Adr.'s share price and its median forecast price. As on 12.10.24, the difference is -12.16%
Gsk Plc-spon Adr. (GSK): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Gsk Plc-spon Adr. (GSK) Share Price : Analyst Recommendation
Based on 33 analysts tracking and researching Gsk Plc-spon Adr. (GSK) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 13 | 12 | 12 |
| Outperform | 5 | 7 | 8 |
| Hold | 12 | 10 | 10 |
| Underperform | 0 | 0 | 0 |
| Sell | 3 | 3 | 3 |
Gsk Plc-spon Adr. (GSK) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Gsk Plc-spon Adr. (GSK) is $45.88, offered by 33 analysts offering 12-month price forecasts.
Gsk Plc-spon Adr. (GSK) has a maximum of 0.17 upside potential, based on 33 analysts offering 12-month price forecasts.
Based on 33 analysts tracking and researching Gsk Plc-spon Adr. (GSK), 60.61% have a buy recommendation. Remaining 39.39% have either sell or hold recommendations.
The latest share price of Gsk Plc-spon Adr. (GSK) is $39.07 as of 12/10/2024.
20 of total 33 analysts offering stock ratings for Gsk Plc-spon Adr. GSK have recommended buy rating.
â‚ą0 US Stocks a/c Opening Fee